Press Release Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma 1 April 2026
Press Release transcosmos announces its Purpose, Vision, and Values for the next phase of growth 1 April 2026
Press Release The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step 1 April 2026
Press Release Hanon Systems Supplies Highly Integrated Cooling Entity for Electric Vehicles 1 April 2026
Press Release Direct Digital Holdings Reports Fourth Quarter and Full Year 2025 Financial Results 31 March 2026
Press Release NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development 31 March 2026
Press Release The $15 Billion Post-Quantum Migration: NIST Standards Are Final, NSA Deadlines Are Set, and Enterprise Cybersecurity Is About to Be Rebuilt from the Ground Up 31 March 2026
